Family Medicine · Jacksonville, FL
NPI
1023080843
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
810 Lane Ave S
Jacksonville, FL, 32205
Phone (904) 783-9680
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
1,965 services
Medicare patients, 2024
310
Average age 73
Drug cost, 2024
$569K
8,855 prescriptions
Company payments, 2025
$210
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory J McHugh was code 99214 (office e&m - established), 590 times for 265 patients. In total Gregory J McHugh billed 1,965 services in 52 codes, and Medicare paid $119K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 590 | 265 | $79.71 | $47K |
| 36415 Venipuncture Blood Collection | Office | 375 | 229 | $8.49 | $3,183 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 224 | 224 | $126.46 | $28K |
| 99213 Office E&M - Established | Office | 192 | 127 | $58.14 | $11K |
| G0008 Administration of influenza virus vaccine | Office | 94 | 91 | $31.66 | $2,976 |
| 90662 Vaccine Product | Office | 89 | 86 | $78.65 | $7,000 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 57 | 41 | $154.70 | $8,818 |
| 90471 Vaccine Administration | Office | 34 | 34 | $12.49 | $425 |
| 81003 Clinical Chemistry | Office | 33 | 28 | $2.20 | $72.6 |
| 71046 X-ray - Chest | Office | 31 | 30 | $20.78 | $644 |
| 90715 Vaccine Product | Office | 28 | 28 | $27.03 | $757 |
| 93000 Electrocardiogram | Office | 23 | 22 | $9.71 | $223 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 13 | 13 | $162.57 | $2,113 |
By year: 2022 $127K for 2,528 services; 2023 $128K for 2,104 services; 2024 $119K for 1,965 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 375 | 229 | $8.49 | $3,183 |
| 81003 Clinical Chemistry | 33 | 28 | $2.20 | $72.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Gregory J McHugh prescribed most often to Medicare patients was Atorvastatin Calcium, with 501 prescriptions and refills. In total Gregory J McHugh wrote 8,855 Medicare prescriptions that cost $569K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 501 | 1,495 | 137 | $4,245 |
| Amlodipine Besylate Generic | 317 | 929 | 92 | $2,156 |
| Hydrochlorothiazide Generic | 308 | 919 | 91 | $1,183 |
| Levothyroxine Sodium Generic | 300 | 844 | 72 | $2,587 |
| Alprazolam Generic | 273 | 292 | 46 | $1,861 |
| Lisinopril Generic | 238 | 717 | 71 | $1,950 |
| Gabapentin Generic | 223 | 443 | 57 | $4,246 |
| Pravastatin Sodium Generic | 190 | 550 | 54 | $2,150 |
| Omeprazole Generic | 169 | 507 | 53 | $2,928 |
| Metformin Hcl Generic | 156 | 433 | 42 | $750 |
| Zolpidem Tartrate Generic | 154 | 221 | 24 | $1,780 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 140 | 397 | 39 | $1,606 |
| Pioglitazone Hcl Generic | 126 | 384 | 34 | $774 |
| Losartan Potassium Generic | 126 | 376 | 39 | $1,079 |
| Rosuvastatin Calcium Generic | 124 | 358 | 37 | $1,249 |
Brand drugs: 810 claims; generic drugs: 8,025 claims; opioid claims: 266.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory J McHugh $210 ($210 in general payments such as food, travel and fees) from 6 companies. The largest payer was Novo Nordisk Inc with $65.58.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.